Drug Type Small molecule drug, Interferons |
Synonyms Pegasys Copegus Combination Pack |
Action agonists, inhibitors, modulators, + [1] |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), IMPDH inhibitors(Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors), RNAP inhibitors(Bacterial DNA-directed RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (04 Jun 2004), |
Regulation- |
Molecular FormulaC8H12N4O5 |
InChIKeyIWUCXVSUMQZMFG-AFCXAGJDSA-N |
CAS Registry36791-04-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hepatitis C, Chronic | United States | 04 Jun 2004 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis, Liver | Phase 3 | United States | 01 Jun 2000 | |
Liver Cirrhosis | Phase 3 | United States | 01 Jun 2000 |
Phase 4 | 377 | Peginterferon+Ribavirin (Peginterferon and Ribavirin) | gpoaxjdcup = mdonmwghte aoscuevyiv (gktdvnygdn, keinocvffl - cninihlckm) View more | - | 13 Dec 2013 | ||
Peginterferon (Peginterferon) | gpoaxjdcup = ggkunhbcrw aoscuevyiv (gktdvnygdn, evnmcvvjps - prvbnwtwph) View more | ||||||
Phase 4 | 21 | Ribavirin+Pegylated Interferon Alfa-2a | ooionkovnl = cnbouroufq wqztjcfbsc (lmfkbblcua, fmrcwfjtft - muedutdxjs) View more | - | 17 Oct 2013 | ||
Phase 3 | 114 | (Pegylated Interferon/Ribavirin) | mcqirtlxzm = sqedmghpsf smxrwjtgbd (dtpyqmggxe, otvupkrfeq - mvjsuqoibf) View more | - | 01 Jul 2013 | ||
(Pegylated Interferon/Placebo) | mcqirtlxzm = cgumcfrwup smxrwjtgbd (dtpyqmggxe, dtpemmezdv - vxwresbmdj) View more | ||||||
Phase 4 | 308 | oiopsxcpih = bmbmmhoffn orouhpbqbp (mcrhcwrlxb, blwhohojnx - djkmkkwtxp) View more | - | 07 Sep 2009 | |||
Phase 3 | 1,050 | (Peginterferon Alfa-2a 90 mcg/Week) | meeijujmea = aeioqhyccf kifaqftjaf (qcoejuitwy, inqelwcgnl - qvssgohnxu) View more | - | 04 Sep 2009 | ||
peginterferon alfa-2a+ribavirin (Standard of Care Followup) | meeijujmea = mubzvgkghh kifaqftjaf (qcoejuitwy, nckmlbdfvn - jmzmcrokpl) View more |